By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Affordable Medicines1.75B57.82%
AvKARE744.73M24.67%
Specialty528.51M17.51%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States3.02B100.00%